genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2014
Uterine cancer
Cancer
Selecta Receives $3.2M from Skolkovo Foundation for Immuno-oncology Program
Cancer
Gene Mutated in Colorectal and Endometrial Cancers Surprises Scientists
Cancer
Avastin Wins FDA Nod for Advanced Forms of Cervical Cancer
Cancer
Antitope to Develop Cell Line for Baylor’s Cancer Vaccine
Cancer
Biocon, Advaxis Ink Deal for HPV-Associated Cervical Cancer Compound
Insights
Stock Watch: Five Companies to Keep an Eye On
Cancer
Single Gene, Once under Radar, Helps Drive 1/100 Cancers
Cancer
CEL-SCI, Ergomed to Co-Develop Head and Neck Cancer Candidate as Potential HPV Treatment
Insights
Gene Test Boom Faces Lawsuits
Cancer
Controlled Access to HeLa Cell Genome Allowed with Lacks Family’s Blessing
1
2
3
4
...
9
Page 3 of 9
Scroll Up
Scroll Up
